Introduction {#sec1}
============

Continued improvement of techniques for identification of mycobacteria has produced a resurgence of interest in diseases caused by species other than *Mycobacterium tuberculosis.* Currently there are more than 150 species of nontuberculous mycobacteria, and more than half are considered definite or potential pathogens in humans [@bib1].

*Mycobacterium monacense* is rapidly growing nontuberculous mycobacteria, first described in 2006 by Reischl *et al.* [@bib2]. The name *monacense* come from Monacum, the Latin name of the German city of Munich, where the first strain was isolated. Subsequently five additional reports [@bib3], [@bib4], [@bib5], [@bib6], [@bib7] have been published that describe infection by this new species. Here we report the first case of *M. monacense* associated with chronic nodular vasculitis infecting a woman in Ecuador.

Erythema induratum was previously described in association with tuberculosis in the middle of the 19th century. The clinical picture is characterized by tender violaceous nodules and plaques most commonly affecting the posterior lower legs (usually calves), with the shins involved less often. The nodules are tender and erythematous (those may ulcerate with bluish borders), and cold weather may be a precipitating factor. About half of the patients have a past or present history of tuberculosis. This is most often pulmonary tuberculosis, with cervical lymphadenopathy second. Erythema induratum often remains undiagnosed or misdiagnosed because it is often mistaken for other types of chronic nodules of the lower extremities.

Case Report {#sec2}
===========

A 29-year-old woman with a previous clinical diagnosis of erythema nodosum 4 months before was admitted to hospital with chronic recurrent nodular lesions in both legs associated with moderate pain and erythema. She had previously received topical steroid injections in the lesions, with partial improvement. Four days before admission, she noted a new nodular lesion on the anterior aspect of her left knee.

The skin lesions were tender erythematous nodules approximately 3 cm in diameter located on the anterior and posterior aspects both legs ([Fig. 1](#fig1){ref-type="fig"}). An ulcerated nodule with an abscess was present on the medial aspect of her left knee. At admission, here complete blood count was 8580 leucocytes with 50.8% neutrophils, hemoglobin 12.4 g/dL and C-reactive protein 68.99 mg/dL. Because of the possibility of erythema induratum, a chest X-ray was conducted, which revealed no pathologic lesions on the lungs. Serology for hepatitis B and C virus was negative.

A deep biopsy of the nodular lesion was performed; the biopsy sample was sent for histopathologic, bacteriologic and mycobacteriologic diagnosis. Results revealed lobular panniculitis consistent with nodular vasculitis ([Fig. 1](#fig1){ref-type="fig"}). Ziehl-Neelsen staining, performed on a direct biopsy sample, was negative for acid-fast bacilli.

The biopsy sample was cultured on chocolate agar, blood agar, MacConkey agar, Lowenstein-Jensen media and Mycobacteria Growth Indicator Tube (MGIT). After 5 days\' growth in MGIT and after 7 days evidence of growth was observed on agar plates as well on Lowenstein-Jensen media but not on MacConkey agar; a rapid test for SD Bioline TB Ag MPT64 was performed, with negative results (Standard Diagnostics, Gyeonggi-do, Korea). Cultures performed using solid media revealed yellow-pigmented colonies. Identification by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF; Bruker Daltonics, Leipzig, Germany) was performed identifying the colonies as *Mycobacterium monacense.* The acquired mass spectra were compared to Mycobacteria Library 2.0 reference spectra using MALDI Biotyper 3.1 software (Bruker). PCR restriction enzyme analysis (PRA)-*hsp65* was performed as described elsewhere [@bib8]. The PRA-*hsp65* assay also identified the isolate as *M. monacense.* The sequencing of *hsp65* and *rpoB* genes confirmed the identity of the *M. monacense* isolate. The analysis of the nucleotide sequences were performed with MEGA 6 6.06 and National Center for Biotechnology Information BLAST (Basic Local Alignment Search Tool; <http://blast.ncbi.nlm.nih.gov/>). The *hsp65* and *rpoB* nucleotide sequences were deposited into GenBank with the following accession numbers: hsp65, KU361326l and rpoB, KU361327.

Susceptibility testing was performed using the rapid growing mycobacteria plate (Sensititre RAPMYCOI; Thermo Scientific, Waltham, MA, USA), showing the following breakpoints (mg/L): trimethoprim/sulfamethoxazole ≤0.25/4.75, linezolid ≤1, ciprofloxacin 1, imipenem 4, moxifloxacin ≤0.25, cefepime 8, cefoxitin 64, amoxicillin/clavulanic acid ≤2/1, amikacin ≤1, ceftriaxone ≤4, doxycycline ≤0.12, minocycline ≤1, tigecycline 0.030, tobramycin 16 and clarithromycin 8. No interpretation of the breakpoints was performed because there are no breakpoints available for *M. monancense* in the international guidelines. In this case, we also performed an Etest, which obtained the same results as RAPMYCOI, which indicates that the Etest may be helpful when access to microdilution is not possible.

The patient received a short course of oral steroids pending the microbiologic and pathologic results, with partial relief of her symptoms. The patient was informed of the diagnosis of *Mycobacterium monacense* by phone, with the recommendation that she go to hospital for the treatment to be adjusted, but the patient did not return for a follow-up consultation.

Discussion {#sec3}
==========

The first description of the species *M. monacense* was made in 2006 in three nonrelated respiratory samples and one tissue biopsy sample from a posttraumatic wound infection [@bib2]. To our knowledge, there are five additional reports on the isolation of *M. monacense* in clinical samples after the initial description ([Table 1](#tbl1){ref-type="table"}). In six respiratory samples [@bib2], [@bib4], [@bib6], [@bib7], the clinical significance of the isolation could not be proved in three. In the two soft tissue infections, the clinical relevance was clarified in one of the cases [@bib5].

Rapidly growing nontuberculous mycobacteria are an increasingly recognized cause of skin and soft tissue infections, with *M. abscessus, M. fortuitum* and *M. chelonae* being the most common species involved. According to the clinical history, the nodular lesions preceded the topical steroid injections on the legs, suggesting that *M. monacense* caused a secondary infection of the lesions, with the port of entry being the steroid injections. Because the patient was lost to follow-up we were unable to perform further evaluation.

Nowadays, MALDI-TOF is a good tool for the diagnosis of rapid growing mycobacteria as long as the bacteria is included in the software database. Further, PCR restriction enzyme analysis has limitations, as sometimes it is not possible to distinguish among species. For these reasons, we consider that sequencing is a must when identifying rapidly growing mycobacteria [@bib9]. In this study, the three techniques we used verified the first identification, confirming the results, but this is not always the case for noncommon rapidly growing mycobacteria or those not previously described.
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![(A) Tender nodular lesions present on anterior aspects of legs. (B) Biopsy sample of nodular lesion revealing lobular panniculitis and lymphocytic vasculitis.](gr1){#fig1}
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Review of Mycobacterium monacense

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Year of isolation   Age (years)   Country   Clinical or underlying condition                                                                                                                                                                                    Sample                                     HIV status   Acid-fast smear   Treatment                                                                            Follow-up                                             Reference
  ------------------- ------------- --------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------ ------------ ----------------- ------------------------------------------------------------------------------------ ----------------------------------------------------- -----------
  1998                80            Germany   Multifocal lung carcinoma and insulin-dependent diabetes mellitus                                                                                                                                                   Bronchial lavage                           Unknown      Unknown           Unknown                                                                              Unknown                                               [@bib2]

  2000--2005          11            Italy     Fistula on his right thigh from accidental deep penetration of screwdriver                                                                                                                                          Fistula                                    Unknown      Unknown           Unknown                                                                              Unknown                                               [@bib2]

  2000--2005          31            Italy     Bronchopneumonitis                                                                                                                                                                                                  Sputum                                     Unknown      Unknown           Unknown                                                                              Unknown                                               [@bib2]

  2000--2005          82            Italy     Suspected lung cancer                                                                                                                                                                                               Sputum                                     Unknown      Unknown           Unknown                                                                              Unknown                                               [@bib2]

  2001--2006          26            Brazil    Meningitis                                                                                                                                                                                                          Cerebrospinal fluid                        Positive     Unknown           Unknown                                                                              Unknown                                               [@bib3]

  2007                36            China     Car accident in Germany. During initial examination of broken clavicle and radius, received thoracic computed tomographic scan revealing large tumor in upper lobe of his lung highly suspicious for tuberculosis   Bronchoalveolar lavage sample and sputum   Negative     Negative          Unknown                                                                              Lost to follow-up                                     [@bib4]

  2007                59            USA       Non--insulin dependent\                                                                                                                                                                                             Tissue biopsy                              Unknown      Unknown           Clarithromycin + levofloxacin[a](#tbl1fna){ref-type="table-fn"}                      At 14-month follow-up, complete\                      [@bib5]
                                              Diabetes mellitus presented with pain, swelling and recurrent pustules of left thumb                                                                                                                                                                                                                                                                                               resolution had occurred and hand function was\        
                                                                                                                                                                                                                                                                                                                                                                                                                                 normal                                                

  2011                43            India     Diabetes                                                                                                                                                                                                            Sputum                                     Negative     Negative          Unknown                                                                              Lost to follow-up                                     [@bib6]

  2012                57            Iran      Chronic pulmonary disease                                                                                                                                                                                           Sputum                                     Unknown      Positive          Antituberculosis first, amikacin + ciprofloxacin[b](#tbl1fnb){ref-type="table-fn"}   24 months later, patient did not experience relapse   [@bib7]
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Clarithromycin 500 mg twice a day and levofloxacin 500 mg twice a day were initiated 2 months after symptoms were first noted and 1 month after the patient was first seen in the emergency room. Clinical response was discernible within 2 weeks; pain began to resolve, and erythema and swelling decreased. By 6 weeks of therapy, the patient was asymptomatic, with minimal swelling and fading erythema.

After the initial 45 days of antituberculosis therapy and the following 45 days of antimicrobial therapy of nontuberculous pulmonary infection (amikacin plus ciprofloxacin), the patient\'s general condition improved.
